Maternal care for anti-D [Rh] antibodies, unspecified trimester (fetus 1)
ICD-10 O36.0191 is a billable code used to indicate a diagnosis of maternal care for anti-d [rh] antibodies, unspecified trimester (fetus 1).
Maternal care for anti-D [Rh] antibodies is critical in managing pregnancies where the mother has developed antibodies against the Rh factor, which can lead to hemolytic disease of the fetus and newborn (HDFN). This condition arises when an Rh-negative mother carries an Rh-positive fetus, leading to the mother's immune system producing antibodies that can cross the placenta and attack fetal red blood cells. The clinical management of this condition involves careful monitoring of the fetus for signs of anemia, growth restriction, and distress. Regular ultrasounds and Doppler studies may be employed to assess fetal well-being and blood flow. Maternal care may also include administering Rh immunoglobulin (RhoGAM) to prevent antibody formation in future pregnancies. The unspecified trimester designation indicates that the care may be applicable at any point during the pregnancy, necessitating ongoing assessment and intervention as needed to ensure both maternal and fetal health.
Detailed records of maternal antibody status, fetal assessments, and any interventions performed.
Routine monitoring of Rh-negative mothers, administration of RhoGAM, and management of fetal distress.
Ensure that all maternal and fetal assessments are documented clearly to support coding.
Comprehensive documentation of high-risk assessments, including ultrasound findings and fetal blood flow studies.
Management of severe fetal anemia, intrauterine transfusions, and close monitoring of growth restriction.
High-risk pregnancies require detailed documentation of all interventions and outcomes.
Used for comprehensive obstetric care in patients with anti-D antibodies.
Document all visits, assessments, and interventions related to the pregnancy.
Ensure coordination with maternal-fetal medicine specialists for high-risk cases.
Anti-D antibodies can lead to serious complications in pregnancies where the mother is Rh-negative and the fetus is Rh-positive. It is crucial to monitor the pregnancy closely to prevent hemolytic disease of the newborn.
